IDEXX Posts $4.01 Third-Quarter EPS
IDXX is trading near its 52-week low of $500.61 (8.7% above the low) on elevated volume (2.2× avg).
Summary
IDEXX reported third-quarter EPS of $4.01, with revenue of $1.21 billion and net income of $317.1 million. The beat/miss picture against consensus isn't yet clear from these figures. The company raised its 2026 outlook to revenue of $4.741 billion-$4.767 billion, EPS of $14.96-$15.16 and organic revenue growth of 9.3%-10%. Context matters here: Q2 2026 came in at $4.27 diluted EPS on $1.217 billion of revenue, with full-year EPS guidance raised to $14.69-$14.94. A $4.01 print is below that Q2 level, so the sequential step-down and any accompanying guidance revision are the things that will decide direction.
At the time of this announcement, IDXX was trading at $544.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $43.4B. The 52-week trading range was $500.61 to $769.98. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.